2025-05-29-Jefferies-WEX（WEX）_税收法案有利于健康储蓄账户；激进投资者推动增加战略行动的可能性_9页_263kb

Equity Research Summary: WEX (WEX)

Overview

• Equity Research from Jefferies dated May 29, 2025.
• Rating: Hold.
• Price Target: $135.00 (indicating a -1% target below the prior day's close).
• The proposed tax bill (BBB) could benefit Health Savings Accounts (HSAs), providing a positive tailwind.
• Activist fund Impactive Capital is pressuring WEX to nominate four directors, aiming to push for strategic actions, likely involving the Benefits segment.
• Our Specific Target Price (SoTP) implies only modest upside to around $150/sh if a spin-off occurs, but carrying challenges including potential tax leakage and dis-synergies.

Tax Bill Tailwinds for Healthcare FSAs (HSAs)

• The BBB tax bill includes measures to boost HSA usage:
  • Increased contribution limits: $8,600 for individuals (<$100k income) and $17,100 for families (<$200k income; double current limits).
  • Medicare Part A enrollees eligible to contribute.
  • Expanded use of HSA funds for new categories (e.g., gym memberships).
  • Ability to move funds from FSAs or HRAs into HSAs.
• Potential impact: Could drive HSA account and asset growth, supporting WEX (which manages HSA assets).

Activist Action and Strategic Considerations

• Impactive Capital: Holds ~7% stake and aims to nominate four directors.
• Goal: To catalyze strategic actions (e.g., spin-off of Benefits segment), potentially increasing shareholder value and alignment.
• If successful in gaining four board seats, this enhances the likelihood of action, but carries risks of dis-synergies and tax-related issues.
• Jefferies believes a spin-off of Benefits (currently ~30% of revenue, ~33% adj. operating profit) might be feasible but is operationally complicated.

Valuation and Sensitivity

• SoTP (Split-Alpha) if Benefits Spun Off:
  • Benefits at 12.5x EBITDA (50 bps to HQY):
    • Assumptions: $90/share implied for Benefits (based on adj. EBITDA estimate).
    • RemainCo:
      • Mobility: 6.5x EBITDA (lower due to sluggish organic growth).
      • Corporate Payments: 5x EBITDA (reflecting share loss and pricing compression).
      • RemainCo EBITDA adjusted down due to dis-synergies.
    • Total Equity Value: $5,427M for the combined entity, yielding ~$151/sh.
  • Benefit assumption: A discount of ~2.5x to industry multiple (HQY), reflecting slower growth in Benefits compared to the fintech sector.

Key Risks and View

• Challenges: Dis-synergies (e.g., WEX Bank integration, tech overlap), tax leakage, and human capital transitions in a spin-off.
• Overall stance: HOLD rating underscores expectations for limited upside amid subdued growth compared to the broader equity market.